Department of Oncology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.
School of Basic Medical Sciences, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.
Int J Nanomedicine. 2021 Feb 12;16:1083-1102. doi: 10.2147/IJN.S290438. eCollection 2021.
Radiotherapy (RT) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors. Although great success has been achieved on radiotherapy, there is still an intractable challenge to enhance radiation damage to tumor tissue and reduce side effects to healthy tissue. Radiosensitizers are chemicals or pharmaceutical agents that can enhance the killing effect on tumor cells by accelerating DNA damage and producing free radicals indirectly. In most cases, radiosensitizers have less effect on normal tissues. In recent years, several strategies have been exploited to develop radiosensitizers that are highly effective and have low toxicity. In this review, we first summarized the applications of radiosensitizers including small molecules, macromolecules, and nanomaterials, especially those that have been used in clinical trials. Second, the development states of radiosensitizers and the possible mechanisms to improve radiosensitizers sensibility are reviewed. Third, the challenges and prospects for clinical translation of radiosensitizers in oncotherapy are presented.
放射治疗(RT)是一种使用高剂量辐射杀死癌细胞和缩小肿瘤的癌症治疗方法。尽管放射治疗取得了巨大的成功,但仍存在一个难以解决的挑战,即增强对肿瘤组织的辐射损伤,同时减少对健康组织的副作用。增敏剂是能够通过加速 DNA 损伤和间接产生自由基来增强对肿瘤细胞杀伤效果的化学物质或药物制剂。在大多数情况下,增敏剂对正常组织的影响较小。近年来,已经开发了几种策略来开发高效低毒的增敏剂。在这篇综述中,我们首先总结了增敏剂的应用,包括小分子、大分子和纳米材料,特别是那些已在临床试验中应用的增敏剂。其次,综述了增敏剂的发展现状和提高增敏剂敏感性的可能机制。第三,提出了增敏剂在肿瘤治疗中临床转化的挑战和前景。